ID

23430

Beschrijving

Effect of Nuts vs. a Wheat Bran Muffin in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00410722

Link

https://clinicaltrials.gov/show/NCT00410722

Trefwoorden

Versies (1)
  1. 04-07-17 04-07-17 -
Geüploaded op

4 juli 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Type 2 Diabetes NCT00410722

Engels

Eligibility Type 2 Diabetes NCT00410722

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
men and post menopausal women with type 2 diabetes treated with diet plus oral hypoglycemic agents (sulfonylureas (glyburide), biguanides (metformin), thiazolidinediones (tzds) and new secretagogues (repaglinide)) at a stable dose for at least 3 months prior to starting the study;
Beschrijving

Gender | Postmenopausal state | Diabetes Mellitus, Non-Insulin-Dependent | Diet therapy | Oral hypoglycemic Dose Stable | Sulfonylurea | Glyburide | Biguanides | Metformin | Thiazolidinediones | repaglinide

Datatype

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0232970
UMLS CUI [3]
C0011860
UMLS CUI [4]
C0012159
UMLS CUI [5,1]
C0359086
UMLS CUI [5,2]
C0178602
UMLS CUI [5,3]
C0205360
UMLS CUI [6]
C0038766
UMLS CUI [7]
C0017628
UMLS CUI [8]
C0005382
UMLS CUI [9]
C0025598
UMLS CUI [10]
C1257987
UMLS CUI [11]
C0246689
hba1c of 6.5 to 8.0% as a compromise between those whose levels are acceptable and the level which is currently considered unacceptable.
Beschrijving

Glycosylated hemoglobin A

Datatype

boolean

Alias
UMLS CUI [1]
C0019018
diabetes diagnosed >6 months prior to randomization
Beschrijving

Diabetes Mellitus disease length

Datatype

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0872146
weight stable within 3% body weight >2 months.
Beschrijving

Stable body weight

Datatype

boolean

Alias
UMLS CUI [1]
C0517386
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of acarbose
Beschrijving

Acarbose

Datatype

boolean

Alias
UMLS CUI [1]
C0050393
use of insulin
Beschrijving

Insulin

Datatype

boolean

Alias
UMLS CUI [1]
C0021641
known nut allergies
Beschrijving

Nut Hypersensitivity

Datatype

boolean

Alias
UMLS CUI [1]
C0577620
clinically significant gastroparesis
Beschrijving

Gastroparesis

Datatype

boolean

Alias
UMLS CUI [1]
C0152020
use of steroids
Beschrijving

Steroids

Datatype

boolean

Alias
UMLS CUI [1]
C0038317
presence of gi disease (celiac disease, ulcerative colitis, and crohns)
Beschrijving

Gastrointestinal Diseases | Celiac Disease | Ulcerative Colitis | Crohn Disease

Datatype

boolean

Alias
UMLS CUI [1]
C0017178
UMLS CUI [2]
C0007570
UMLS CUI [3]
C0009324
UMLS CUI [4]
C0010346
major cardiovascular event (stroke or myocardial infarction)
Beschrijving

Cardiovascular event Major | Cerebrovascular accident | Myocardial Infarction

Datatype

boolean

Alias
UMLS CUI [1,1]
C1320716
UMLS CUI [1,2]
C0205164
UMLS CUI [2]
C0038454
UMLS CUI [3]
C0027051
major surgery < 6 months prior to randomization
Beschrijving

major surgery

Datatype

boolean

Alias
UMLS CUI [1]
C0679637
presence of major debilitating disorder such as clinically significant liver disease (not including non-alcoholic fatty liver (nafl) or non-alcoholic steatohepatitis (nash) but including cirrhosis, infectious hepatitis (b and c), aspartate transaminase (ast) or alanine transaminase (alt) > 130 iu/l)
Beschrijving

Debilitation Major | Liver diseases | Non-alcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Liver Cirrhosis | HEPATITIS B INFECTIOUS | Hepatitis C | Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Datatype

boolean

Alias
UMLS CUI [1,1]
C0742985
UMLS CUI [1,2]
C0205164
UMLS CUI [2]
C0023895
UMLS CUI [3]
C0400966
UMLS CUI [4]
C3241937
UMLS CUI [5]
C0023890
UMLS CUI [6]
C0744836
UMLS CUI [7]
C0019196
UMLS CUI [8]
C0201899
UMLS CUI [9]
C0201836
renal failure (high creatinine > 150 mmol/l)
Beschrijving

Kidney Failure | Creatinine increased

Datatype

boolean

Alias
UMLS CUI [1]
C0035078
UMLS CUI [2]
C0151578
serum triglyceride > 6 mmol/l.
Beschrijving

Serum Triglyceride Measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0542495
patients currently undergoing treatment for cancer with the exception of non-melanoma skin cancer, but not high risk patients or those whose treatment has been successfully completed.
Beschrijving

Cancer treatment | Skin carcinoma | High risk Absent | Treatment completed Successful

Datatype

boolean

Alias
UMLS CUI [1]
C0920425
UMLS CUI [2]
C0699893
UMLS CUI [3,1]
C0332167
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0580352
UMLS CUI [4,2]
C1272703
Terug naar het begin van de pagina

Similar models

Eligibility Type 2 Diabetes NCT00410722

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Postmenopausal state | Diabetes Mellitus, Non-Insulin-Dependent | Diet therapy | Oral hypoglycemic Dose Stable | Sulfonylurea | Glyburide | Biguanides | Metformin | Thiazolidinediones | repaglinide
Item
men and post menopausal women with type 2 diabetes treated with diet plus oral hypoglycemic agents (sulfonylureas (glyburide), biguanides (metformin), thiazolidinediones (tzds) and new secretagogues (repaglinide)) at a stable dose for at least 3 months prior to starting the study;
boolean
C0079399 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C0011860 (UMLS CUI [3])
C0012159 (UMLS CUI [4])
C0359086 (UMLS CUI [5,1])
C0178602 (UMLS CUI [5,2])
C0205360 (UMLS CUI [5,3])
C0038766 (UMLS CUI [6])
C0017628 (UMLS CUI [7])
C0005382 (UMLS CUI [8])
C0025598 (UMLS CUI [9])
C1257987 (UMLS CUI [10])
C0246689 (UMLS CUI [11])
Glycosylated hemoglobin A
Item
hba1c of 6.5 to 8.0% as a compromise between those whose levels are acceptable and the level which is currently considered unacceptable.
boolean
C0019018 (UMLS CUI [1])
Diabetes Mellitus disease length
Item
diabetes diagnosed >6 months prior to randomization
boolean
C0011849 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Stable body weight
Item
weight stable within 3% body weight >2 months.
boolean
C0517386 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Acarbose
Item
use of acarbose
boolean
C0050393 (UMLS CUI [1])
Insulin
Item
use of insulin
boolean
C0021641 (UMLS CUI [1])
Nut Hypersensitivity
Item
known nut allergies
boolean
C0577620 (UMLS CUI [1])
Gastroparesis
Item
clinically significant gastroparesis
boolean
C0152020 (UMLS CUI [1])
Steroids
Item
use of steroids
boolean
C0038317 (UMLS CUI [1])
Gastrointestinal Diseases | Celiac Disease | Ulcerative Colitis | Crohn Disease
Item
presence of gi disease (celiac disease, ulcerative colitis, and crohns)
boolean
C0017178 (UMLS CUI [1])
C0007570 (UMLS CUI [2])
C0009324 (UMLS CUI [3])
C0010346 (UMLS CUI [4])
Cardiovascular event Major | Cerebrovascular accident | Myocardial Infarction
Item
major cardiovascular event (stroke or myocardial infarction)
boolean
C1320716 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0038454 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
major surgery
Item
major surgery < 6 months prior to randomization
boolean
C0679637 (UMLS CUI [1])
Debilitation Major | Liver diseases | Non-alcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Liver Cirrhosis | HEPATITIS B INFECTIOUS | Hepatitis C | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
presence of major debilitating disorder such as clinically significant liver disease (not including non-alcoholic fatty liver (nafl) or non-alcoholic steatohepatitis (nash) but including cirrhosis, infectious hepatitis (b and c), aspartate transaminase (ast) or alanine transaminase (alt) > 130 iu/l)
boolean
C0742985 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0023895 (UMLS CUI [2])
C0400966 (UMLS CUI [3])
C3241937 (UMLS CUI [4])
C0023890 (UMLS CUI [5])
C0744836 (UMLS CUI [6])
C0019196 (UMLS CUI [7])
C0201899 (UMLS CUI [8])
C0201836 (UMLS CUI [9])
Kidney Failure | Creatinine increased
Item
renal failure (high creatinine > 150 mmol/l)
boolean
C0035078 (UMLS CUI [1])
C0151578 (UMLS CUI [2])
Serum Triglyceride Measurement
Item
serum triglyceride > 6 mmol/l.
boolean
C0542495 (UMLS CUI [1])
Cancer treatment | Skin carcinoma | High risk Absent | Treatment completed Successful
Item
patients currently undergoing treatment for cancer with the exception of non-melanoma skin cancer, but not high risk patients or those whose treatment has been successfully completed.
boolean
C0920425 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
C0332167 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0580352 (UMLS CUI [4,1])
C1272703 (UMLS CUI [4,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial